Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2164316547', 'doi': 'https://doi.org/10.2147/ott.s4943', 'title': 'Multiple roles and therapeutic implications of Akt signaling in cancer', 'display_name': 'Multiple roles and therapeutic implications of Akt signaling in cancer', 'publication_year': 2009, 'publication_date': '2009-06-01', 'ids': {'openalex': 'https://openalex.org/W2164316547', 'doi': 'https://doi.org/10.2147/ott.s4943', 'mag': '2164316547', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20616901', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/2886325'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/ott.s4943', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=4927', 'source': {'id': 'https://openalex.org/S120324992', 'display_name': 'OncoTargets and Therapy', 'issn_l': '1178-6930', 'issn': ['1178-6930'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.dovepress.com/getfile.php?fileID=4927', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5078740280', 'display_name': 'Victoria Bolós', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210138890', 'display_name': 'Pfizer (Spain)', 'ror': 'https://ror.org/03x2xt559', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210138890']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Victoria Bolós', 'raw_affiliation_strings': ['Pfizer Oncology, Alcobendas-Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Oncology, Alcobendas-Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210138890']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053069942', 'display_name': 'Emiliano Calvo', 'orcid': 'https://orcid.org/0000-0003-4921-829X'}, 'institutions': [{'id': 'https://openalex.org/I4210096786', 'display_name': 'Centro Oncológico de Galicia', 'ror': 'https://ror.org/00swmft88', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210096786']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Emiliano Calvo', 'raw_affiliation_strings': ['Centro Integral Oncológico Clara Campal (CiOCC), Madrid. Spain'], 'affiliations': [{'raw_affiliation_string': 'Centro Integral Oncológico Clara Campal (CiOCC), Madrid. Spain', 'institution_ids': ['https://openalex.org/I4210096786']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078740280', 'display_name': 'Victoria Bolós', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210138890', 'display_name': 'Pfizer (Spain)', 'ror': 'https://ror.org/03x2xt559', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210138890']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Victoria Bolós', 'raw_affiliation_strings': ['Pfizer Oncology, Alcobendas-Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Oncology, Alcobendas-Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210138890']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5038614419', 'display_name': 'Enrique Grande', 'orcid': 'https://orcid.org/0000-0002-0134-4732'}, 'institutions': [{'id': 'https://openalex.org/I4210138890', 'display_name': 'Pfizer (Spain)', 'ror': 'https://ror.org/03x2xt559', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210138890']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Enrique Grande', 'raw_affiliation_strings': ['Pfizer Oncology, Alcobendas-Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Oncology, Alcobendas-Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210138890']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2836, 'currency': 'USD', 'value_usd': 2836, 'provenance': 'doaj'}, 'apc_paid': {'value': 2836, 'currency': 'USD', 'value_usd': 2836, 'provenance': 'doaj'}, 'fwci': 0.847, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 22, 'citation_normalized_percentile': {'value': 0.796268, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': None, 'issue': None, 'first_page': '135', 'last_page': '135'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9384, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9384, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9199, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C75217442', 'wikidata': 'https://www.wikidata.org/wiki/Q423650', 'display_name': 'Protein kinase B', 'level': 3, 'score': 0.67323387}, {'id': 'https://openalex.org/C2779490328', 'wikidata': 'https://www.wikidata.org/wiki/Q417542', 'display_name': 'Sunitinib', 'level': 3, 'score': 0.6668736}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6624692}, {'id': 'https://openalex.org/C86554907', 'wikidata': 'https://www.wikidata.org/wiki/Q285613', 'display_name': 'PI3K/AKT/mTOR pathway', 'level': 3, 'score': 0.6330791}, {'id': 'https://openalex.org/C2779536868', 'wikidata': 'https://www.wikidata.org/wiki/Q419940', 'display_name': 'Dasatinib', 'level': 4, 'score': 0.5647376}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.54476047}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.5166221}, {'id': 'https://openalex.org/C101544691', 'wikidata': 'https://www.wikidata.org/wiki/Q420511', 'display_name': 'Receptor tyrosine kinase', 'level': 3, 'score': 0.45882678}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.45810768}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.45072344}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40152717}, {'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.3615501}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.34338668}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.3048034}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.30397326}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.24540171}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.15936133}], 'mesh': [], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/ott.s4943', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=4927', 'source': {'id': 'https://openalex.org/S120324992', 'display_name': 'OncoTargets and Therapy', 'issn_l': '1178-6930', 'issn': ['1178-6930'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2886325', 'pdf_url': 'https://europepmc.org/articles/pmc2886325?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886325', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20616901', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/ott.s4943', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=4927', 'source': {'id': 'https://openalex.org/S120324992', 'display_name': 'OncoTargets and Therapy', 'issn_l': '1178-6930', 'issn': ['1178-6930'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.81, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4253096022', 'https://openalex.org/W2941817612', 'https://openalex.org/W2618548116', 'https://openalex.org/W2184534421', 'https://openalex.org/W2163329109', 'https://openalex.org/W2139973222', 'https://openalex.org/W2092828011', 'https://openalex.org/W2064607797', 'https://openalex.org/W1993369250', 'https://openalex.org/W1983852790'], 'abstract_inverted_index': {'Abstract:': [0], 'The': [1, 60, 185], 'prominence': [2], 'of': [3, 30, 33, 57, 68, 118, 187, 203], 'the': [4, 31, 50, 55, 58, 121, 127, 130, 188, 201], 'PI3K-Akt': [5], 'signaling': [6, 190], 'pathway': [7, 159, 191], 'in': [8, 54, 100, 129, 138, 192], 'several': [9], 'tumors': [10, 34], 'indicates': [11], 'a': [12], 'relationship': [13], 'with': [14], 'tumor': [15], 'grade': [16], 'and': [17, 49, 78, 92, 115, 141, 157, 167, 175, 181, 197], 'proliferation.': [18], 'Critical': [19], 'cellular': [20], 'processes': [21], 'are': [22, 135, 161], 'driven': [23], 'through': [24], 'this': [25], 'pathway.': [26], 'More': [27], 'detailed': [28], 'knowledge': [29], 'pathogenesis': [32], 'would': [35], 'enable': [36], 'us': [37], 'to': [38, 42, 113, 200], 'design': [39], 'targeted': [40], 'drugs': [41], 'block': [43, 208], 'both': [44, 117], 'membrane': [45], 'tyrosine': [46, 80], 'kinase': [47, 81, 86], 'receptors': [48], 'intracellular': [51, 122, 176], 'kinases': [52], 'involved': [53], 'transmission': [56], 'signal.': [59], 'newly': [61], 'approved': [62], 'molecular': [63], 'inhibitors': [64, 217], 'sunitinib': [65], '(an': [66, 94], 'inhibitor': [67, 87], 'vascular': [69], 'endothelial': [70], 'growth': [71, 75], 'factor': [72, 76], 'receptor,': [73, 77], 'platelet-derived': [74], 'other': [79], 'receptors),': [82], 'sorafenib': [83], '(a': [84], 'serine–threonine': [85], 'that': [88, 172, 207], 'acts': [89], 'against': [90], 'B-Raf)': [91], 'temsirolimus': [93], 'mTOR': [95], 'inhibitor)': [96], 'shown': [97], 'clinical': [98, 169], 'activity': [99], 'advanced': [101], 'kidney': [102], 'cancer.': [103], 'Chronic': [104], 'myeloid': [105], 'leukemia': [106], 'has': [107, 148, 198], 'changed': [108], 'its': [109, 209], 'natural': [110], 'history': [111], 'thanks': [112], 'imatinib': [114], 'dasatinib,': [116], 'which': [119], 'inhibit': [120], 'bcr/abl': [123], 'protein': [124], 'derived': [125], 'from': [126], 'alteration': [128], 'Philadelphia': [131], 'chromosome.': [132], 'Intracellular': [133], 'pathways': [134], 'still': [136], 'important': [137], 'cancer': [139, 193], 'development': [140, 202], 'their': [142], 'blockade': [143, 160], 'directly': [144], 'affects': [145], 'outcome.': [146], 'Cross-talk': [147], 'been': [149], 'observed': [150], 'but': [151], 'is': [152, 194], 'not': [153], 'well': [154, 195], 'understood.': [155], 'Vertical': [156], 'horizontal': [158], 'promising': [162], 'anticancer': [163, 205], 'strategies.': [164], 'Indeed,': [165], 'preclinical': [166], 'early': [168], 'data': [170], 'suggest': [171], 'combining': [173], 'superficial': [174], 'blocking': [177], 'agents': [178, 206], 'can': [179], 'synergize': [180], 'leverage': [182], 'single-agent': [183], 'activity.': [184], 'implication': [186], 'Akt': [189, 216], 'established': [196], 'led': [199], 'new': [204], 'activation.': [210], 'Keywords:': [211], 'Akt,': [212], 'cancer,': [213], 'therapeutic': [214], 'target,': [215]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2164316547', 'counts_by_year': [{'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 2}, {'year': 2018, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2024-12-16T00:27:36.733491', 'created_date': '2016-06-24'}